SAN DIEGO, April 28, 2025--Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and a part of JSR Life Sciences and Japan-based JSR Corporation, today ...

Crown Bioscience Publishes New Study in PLOS ONE Highlighting the Use of Clinically Relevant 3D In Vitro PDX-Derived Organoid Models as Powerful Tools to Accelerate Cancer Drug Discovery ...

Crown Bioscience’s paper highlights the robustness and reproducibility of 3D in vitro organoid technology as well as the genetic and phenotypic stability compared to the original tumor material.